Introduction. The factors related to neurological complications and evaluation of treatment outcomes in COVID-19 patients are still very limited.
The objective of our study was to evaluate the treatment outcomes of neurological complications in post COVID-19 patients in Vietnam.
Material and methods. A cross – sectional study with 4 weeks follow-up was conducted on 345 COVID-19 patients. Verbal Rating Scale (VRS), Dizziness Assessment Rating Scale (DARS), and modified Rankin Scale (mRS) were used.
Results. The study revealed that the prevalence of neurological complications after COVID-19 was 48.7%, mostly mild, with a low proportion of severe complications. A body mass index (BMI) ≥ 23 Kg/m2 increased the risk of complications by 2.026 times (95% CI 1.245-3.298, p=0.004) and the history of severe COVID-19 increased the risk of complications by OR 3.56 (95% CI 1.409-9.000, p=0.007). The results of treating headache and dizziness were good, all VRS and DARS scores before treatment being 3–4 points, and decreased to 1–2 points. However, stroke still appeared in 17.6% of patients who had a high mRS score (>2).
Conclusions. The prevalence of neurological complications after COVID-19 was high; most complications were mild, and a low percentage of patients had severe complications. The outcomes of neurological complications treatment were good, with a low rate of impact on quality of life.
Keywords: COVID-19, neurological complications, Verbal Rating Scale (VRS), Dizziness Assessment Rating Scale (DARS), modified Rankin Scale (mRS).
Full text sources https://doi.org/10.31688/ABMU.2024.59.2.03
How to cite
Email to Author
Address for correspondence:
Toan Hoang NGO
Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho City 90000, Vietnam
Email: nhtoan@ctump.edu.vn, Phone +84 366592309